Durable Disease Control With Atezolizumab Plus Bevacizumab but Limited Post-Progression Outcomes: A Multicenter Real-World Study in Advanced Hepatocellular Carcinoma
阿特珠单抗联合贝伐珠单抗可实现持久的疾病控制,但疾病进展后的疗效有限:一项针对晚期肝细胞癌的多中心真实世界研究
期刊:Cancer Medicine
影响因子:3.1
doi:10.1002/cam4.71655
Inoue, Masanori; Ogasawara, Sadahisa; Asahara, Kazuhisa; Sato, Rui; Watanabe, Shunji; Anzai, Haruka; Tsubura, Kazuo; Watabe, Taro; Fujiya, Makoto; Akatsuka, Teppei; Izai, Ryo; Katayama, Keiichi; Sawada, Midori; Tsuchiya, Takahiro; Miwa, Chihiro; Yoshino, Ryohei; Yonemoto, Takuya; Fujimoto, Kentaro; Unozawa, Hidemi; Yumita, Sae; Kanzaki, Hiroaki; Koroki, Keisuke; Kobayashi, Kazufumi; Nakamura, Masato; Kanogawa, Naoya; Nakamoto, Shingo; Yokoyama, Masayuki; Kato, Jun; Moriguchi, Michihisa; Aramaki, Takeshi; Morimoto, Naoki